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Introduction: There’s a consensus to perform chromosomal microarray 
technique as first-tier clinical diagnostic test for individuals with developmental 
disabilities. However, given the complexity of clinical presentations, often several 
diagnostic methods are held before conducting microarray. 
 
Method: We report the case of a 5 year-old boy referred to Medical Genetics due 
to short stature, developmental disabilities and facial dysmorphic features. 
He was born from eutocic delivery after an uneventful pregnancy. He had 
psychomotor milestones delayed like sitting at 9 months and walking at 24 
months, holding an immature broad-based gait. There was history of learning 
difficulties from both parents, and the mother has also short stature.  
On examination it was noted some facial dysmorphic features like high forehead, 
conical canines and rarefaction of the distal portion of the eyebrows. 
Due to the history of an episode of transient ataxia, and suspicion of an inherited 
metabolic disorder, he had already performed various analytical and imaging 
screenings, all normal. 
 
Results: Chromosomal microarray analysis revealed two pathogenic Copy 
Number Variants (CNV’s): 16p11.2 deletion and 15q11.2q13.1 duplication.  
The 15q11q13 microduplication syndrome (OMIM # 608636) is a very rare clinical 
entity with about 30 reported cases with maternal origin, and it is characterized by 
neurobehavioral disorder, hypotonia, cognitive impairment, epilepsy and short 
stature.  
The 16p11.2 microdeletion syndrome (OMIM # 613444) is also a rare clinical 
entity, with high penetrance, associated with obesity and developmental 
disabilities.  
 
Discussion: Despite the unquestionable utility of microarray, the correlation of 
the CNV's with the phenotype is often difficult by the rarity of these new 
microdeletion/duplication clinical entities. In this case the interpretation has 
increased difficulty because of the simultaneous existence of two distinct clinical 
entities. Segregation studies, which in the first step include parental analysis, are 
essential for genetic counseling and determining the risk of recurrence but also 
for a more accurate correlation genotype-phenotype. 
 
